Carregant...
Genetic test reporting of CDKN2A provides informational and motivational benefits for managing melanoma risk
A CDKN2A/p16 mutation confers 28%–67% lifetime melanoma risk, a risk that may be moderated by ultraviolet radiation exposure. The aim of this study was to test whether melanoma genetic counseling and test disclosure conferred unique informational, motivational, or emotional benefits compared to fami...
Guardat en:
| Publicat a: | Transl Behav Med |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6065541/ https://ncbi.nlm.nih.gov/pubmed/29385581 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/tbm/ibx011 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|